Following up on a strong earnings report from Wednesday, hi-tech glassmaker Corning (NYSE: GLW ) offered further details this morning on its plans for the future.
Specifically, Corning announced plans to capitalize upon a coming wave in new environmental regulation of heavy-duty engines in Europe and China, by investing similarly heavily in its production of diesel emissions control products.
Corning says it will spend about $250 million on capital improvements in its Environmental Technologies�&�Life Sciences�Business Group, hoping to double its revenues from the group by 2017. Corning will spend to increase capacity at its Erwin diesel facility, which manufactures large ceramic substrates and filters for heavy-duty diesel engine, truck, construction, and agricultural equipment manufacturers.
However, all this new spending will not affect Corning's forecast for 2013 capital expenditures, the company assured investors. Yesterday, Corning pegged 2013 capex spending at approximately $1.3 billion, down from last year's $1.8 billion. With investments in clean diesel being spread out over the next three years, Corning has already figured this investment into capital spending projections for 2013 and 2014. The company gave no such assurances for 2015, however, when the expanded diesel facilities should go into operation.
Hot Heal Care Companies To Watch For 2016: Teekay Lng Partners L.P.(TGP)
Teekay LNG Partners L.P. provides marine transportation services for liquefied natural gas, liquefied petroleum gas, and crude oil worldwide. It transports liquid petroleum gases, including propane, butane, and methane; petrochemical gases comprising ethylene, propylene, and butadiene; and ammonia. The company provides its services through a time-charter or bareboat charter contract basis. As of August 16, 2011, it operated a fleet of 21 LNG carriers, including 1 LNG regasification unit; 5 LPG/multigas carriers; and 11 conventional tankers. Teekay GP L.L.C. serves as the general partner of Teekay LNG Partners L.P. The company was founded in 2004 and is headquartered in Hamilton, Bermuda. Teekay LNG Partners L.P. is a subsidiary of Teekay Corporation.
Advisors' Opinion:- [By Robert Rapier]
The third and most speculative category of MLP that should benefit from expanding US natural gas production is engaged in building and operating LNG export terminals, or in the operation of ships that carry LNG. As US LNG exports ramp up in the years ahead, partnerships that own fleets of special LNG carriers, like�GasLog Partners�(NYSE: GLOP),�Teekay LNG Partners�(NYSE: TGP) and�Golar LNG�(Nasdaq: GLNG) should flourish.
- [By Value Investor]
In terms of valuation the company is trading at an attractive price and investors can consider this as a good investment point. GasLog Partners has the lowest EV/EBITDA and EV/Revenue compared to peers such as Golar LNG (GLNG) and Teekay LNG Partners (TGP). A low EV/EBITDA and EV/Revenue suggests undervaluation of the company and hence a good value investment.
- [By Taylor Muckerman and Joel South]
Aside from the potential growth in exports from North America, Australia looks to be the largest contributor to the growth of natural gas finding its way into the international trade market. Transportation of natural gas chilled to temperatures as low as -260 degrees Fahrenheit certainly requires a high degree of skilled execution. That's where Teekay LNG Partners (NYSE: TGP ) enters the picture. With a fleet much younger than the industry average and a distribution over 6%, it could be a great second-degree play on the coming trend.
10 Best Life Sciences Stocks To Buy For 2015: First Trust Health Care AlphaDEX Fund (FXH)
First Trust Health Care AlphaDEX Fund (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the StrataQuant Health Care Index (the Index). The Index is an enhanced index created and administered by the AMEX, which employs the AlphaDEX stock selection methodology to select stocks from the Russell 1000 Index. The AMEX constructs the Index by ranking the stocks, which are members of the Russell 1000 Index on growth factors, including 3, 6 and 12-month price appreciation, sales to price and one-year sales growth, and separately on value factors, including book value to price, cash flow to price and return on assets. The selected stocks are divided into quintiles based on their rankings and the top ranked quintiles receive a higher weight within the Index. The Index is reconstituted and rebalanced quarterly. The Fund�� investment advisor is First Trust Advisors L.P. Advisors' Opinion:- [By MONEYMORNING.COM]
That's why investors would do well to take a good look at First Trust Health Care AlphaDEX (NYSE: FXH) ("First Trust Healthcare"). This investment gives us access to several sectors within the overall healthcare field. These include pharmaceuticals, life sciences tools, medical equipment and services, as well as biotech and healthcare providers.
- [By David Fabian]
Another interesting ETF that treads the line between passive and active investing in the healthcare field is the First Trust Health Care AlphaDEX Fund (FXH). This ETF is a smart beta strategy that screens healthcare stocks for book value, cash flow, and return on assets.
10 Best Life Sciences Stocks To Buy For 2015: Orbitz Worldwide Inc.(OWW)
Orbitz Worldwide, Inc. operates as an online travel company worldwide. It enables leisure and business travelers to search for and book a range of travel products and services. The company offers various products and services comprising air travel, hotels, vacation packages, car rentals, cruises, travel insurance, as well as destination services, such as ground transportation, event tickets, and tours. Its brand portfolio includes Orbitz, CheapTickets, The Away Network, and Orbitz for Business in the United States; ebookers in Europe; and HotelClub and RatesToGo internationally. Orbitz Worldwide, Inc. also licenses its technology and business services to third parties, such as airlines and hotel partners and provides them various private label solutions, including building and hosting of custom Websites and supplying content feeds to partners' Websites. The company was founded in 2000 and is headquartered in Chicago, Illinois. Orbitz Worldwide, Inc. is a subsidiary of Trav elport Limited.
Advisors' Opinion:- [By Sean Williams]
On Wednesday, Republic Airways (NASDAQ: RJET ) -owned Frontier Airlines announced that it, too, plans to join the carry-on-bag-charging club. However, Frontier's carry-on baggage charge, which will range from $25 to $100, is unique in that it doesn't slap every customer with the charge as Spirit and Allegiant currently do. Instead, carry-on bags will remain free for customers who book their flights through Frontier, but an added charge will apply for customers who book their flight through third-party websites such as Expedia (NASDAQ: EXPE ) and Orbitz (NYSE: OWW ) which typically offer cheaper flight prices than what you'll find on airline companies' websites.
- [By Douglas A. McIntyre]
9. Orbitz Worldwide Inc. (NYSE: OWW) (4.3). The online travel company owns several brands, including Orbitz, CheapTickets and eBookers.com. Total revenue in the most recent quarter was $221 million. Orbitz made $13 million.
- [By Louis Navellier]
Travelers are getting ready to hit the roads and the skies for the upcoming holiday. If you haven’t booked your tickets, you may have to pay a hefty price. But are shares of Orbitz Worldwide (OWW) overpriced?
10 Best Life Sciences Stocks To Buy For 2015: Flexion Therapeutics Inc (FLXN)
Flexion Therapeutics, Inc. (Flexion Therapeutics), incorporated on November 5, 2007, is a pharmaceutical company focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis, referred to as OA. The Company�� portfolio of small molecule product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company�� product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. FX007 is a locally administered TrkA receptor antagonist for persistent relief of post-operative pain, including in patients who have received total joint replacement, also referred to as total joint arthroplasty (TJA). Its product candidates are designed to deliver established anti-inflammatory and analgesic effects directly to the site of disease, optimizing sustained local drug concentration to achieve a durable and clinically meaningful response. These product candidates are also designed to limit systemic exposure to the drugs and minimize systemic toxicities.
FX006 - Front Line IA Therapy for Patients with Moderate to Severe OA Pain
FX006 is a steroid, triamcinolone acetonide (TCA), formulated for sustained-release, delivered through intra-articular (IA) injection and designed to treat moderate to severe OA pain. FX006 combines commonly administered TCA with poly lactic-co-glycolic acid (PLGA), its injectable IA sustained-release technology. As of January 8, 2014, two clinical trials had been conducted to test FX006 against immediate-release TCA injection. FX006 has been studied in two clinical trials, in which a total of 196 patients received FX006! and a total of 56 patients received immediate-release TCA: Study FX006-2011-001 and Study FX006-2011-002.
FX007-For Post-Operative Pain
FX007 is a small molecule TrkA receptor antagonist that is in development for the persistent relief of post-operative pain. TrkA is the receptor for nerve growth factor, commonly known as NGF, a small peptide that is released following tissue injury. NGF binds to TrkA on the surface of pain sensing neurons and renders these cells more responsive to external stimuli.
FX005-For End-Stage OA Pain
FX005 is intended as therapy for patients with end-stage OA pain, particularly those patients awaiting TJA, as an alternative to opioids. FX005 is a p38 MAP, or mitogen-activated protein, kinase inhibitor formulated for sustained-release delivered through IA injection, which is designed to have both analgesic and anti-inflammatory benefits without the systemic side effects of oral p38 MAP kinase inhibitors. p38 MAP kinase is an enzyme in an inflammatory cascade that upregulates in response to stress and culminates in the elaboration of multiple proinflammatory cytokines, including interleukin 1 and tumor necrosis factor, as well as enzymes like matrix metalloproteinases that have the potential to destroy cartilage. In other studies, multiple oral p38 MAP kinase inhibitors have been evaluated in inflammatory diseases and pain and, while efficacy has been demonstrated, serious toxicity affecting multiple organ systems has been frequently observed. FX005 has completed a Phase-II A clinical trial, in which 70 patients were randomized to FX005 and 70 patients were randomized to placebo.
The Company competes with Fidia Farmaceutici S.p.A, Ampio Pharmaceuticals, Inc., Carbylan BioSurgery, Inc., Merck Serono and Allergan, Inc., Pacira Pharmaceuticals, Janssen Pharmaceuticals, Inc. and Johnson & Johnson.
Advisors' Opinion:- [By John Udovich]
It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:
10 Best Life Sciences Stocks To Buy For 2015: Ishares Trust Russell (IWD)
iShares Russell 1000 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the large-capitalization value sector of the United States equity market, as represented by the Russell 1000 Value Index (the Index). The Index is a subset of the Russell 1000 Index. The Index is a capitalization-weighted index and consists of those companies or portion of a company, with lower price-to-book ratios and lower forecasted growth within the Russell 1000 Index. The Index represents approximately 51% of the total market capitalization of the Russell 1000 Index.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to Index. iShares Russell 1000 Value Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By James Brumley]
It’s been especially untrue the last few years. Since this point in the year back in 2003, the iShares Russell 1000 Growth Fund (IWF) has advanced 81%, while the iShares Russell 1000 Value Fund (IWD) has only advanced 67%.
10 Best Life Sciences Stocks To Buy For 2015: Whitecap Resources Inc (SPGYF.PK)
Whitecap Resources Inc., formerly Spitfire Energy Ltd., is engaged in the exploration, development and production of crude oil, natural gas and natural gas liquids in Western Canada. The Company�� activities are concentrated primarily in Northwest Central Alberta and Southwest Saskatchewan. On July 1, 2010, the Company amalgamated with its wholly owned subsidiary Whitecap Resources Inc. During fiscal 2010, the Company produced an average of 355 barrels of oil equivalent per day (boed). On July 12, 2010, the Company entered into an agreement to acquire a private company. The primary assets to be acquired are located in the Pembina region of west central Alberta with production and reserves focused in the Cardium formation. In October 2013, the Company announced that it has completed the acquisition of a Cardium light oil property and a working interest consolidation of its Eagle Lake Viking unit. Advisors' Opinion:- [By Caiman Valores]
The recent surge in oil prices has renewed investor interest in the small-cap oil and gas E&P sector. One company that stands out for all the right reasons is Canadian domiciled small-cap, Whitecap Resources (SPGYF.PK). Since 2009 the company has unlocked considerable value for investors through a range of acquisitions as well as development and exploration projects. This has seen its share price surge in value to be up by almost 53% over the last year alone. However, it is clear that the market has yet to fully recognize the true value of Whitecap and there is still considerable upside potential of over 30% for investors. This along with Whitecap's dividend growth strategy makes it a particularly appealing deep-value investment in the oil and gas E&P sector.
10 Best Life Sciences Stocks To Buy For 2015: 3M Company(MMM)
3M Company, together with subsidiaries, operates as a diversified technology company worldwide. The company?s Industrial and Transportation segment offers tapes, coated and non-woven abrasives, adhesives, specialty materials, filtration products, energy control products, closure systems for personal hygiene products, acoustic systems products, and components and products that are used in the manufacture, repair, and maintenance of automotive, marine, aircraft, and specialty vehicles. Its Health Care segment provides medical and surgical supplies, skin health and infection prevention products, inhalation and transdermal drug delivery systems, dental and orthodontic products, health information systems, and food safety products. The company?s Display and Graphics offers optical film solutions for LCD electronic displays; computer screen filters; reflective sheeting for transportation safety; commercial graphics sheeting and systems; and mobile interactive solutions, includin g mobile display technology, visual systems products, and computer privacy filters. The company?s Consumer and Office segment provides office supply products, stationery products, construction and home improvement products, home care products, protective material products, certain consumer retail personal safety products, and consumer health care products. Its Safety, Security and Protection Services segment offers personal protection products, safety and security products, cleaning and protection products for commercial establishments, track and trace solutions, and roofing granules for asphalt shingles. The company?s Electro and Communications segment provides packaging and interconnection devices; fluids that are used in the manufacture of computer chips, and for cooling electronics and lubricating computer hard disk drives; high-temperature and display tapes; insulating materials, including tapes and resins; and related items. The company was founded in 1902 and is based in St. Paul, Minnesota.
Advisors' Opinion:- [By Ben Levisohn]
General Electric’s industrial units hummed along. It announced plans to shed it consumer-finance business. And its shares, which returned 37% in 2013, kept pace with Danaher (DHR) and United Technologies (UTX), even if they lagged 3M’s (MMM) 54% gain.
- [By Alex Planes]
3M (NYSE: MMM ) was formed on June 13, 1902, when five Minnesota businessmen came together to incorporate the Minnesota Mining and Manufacturing Company in the Lake Superior shorefront village of Two Harbors. The five co-founders each contributed $1,000 to build a company that would capitalize on the discovery of "corundum," an extremely tough mineral that could be used in grinding wheels. 3M's formation was a great example of the "move fast and break things" philosophy a century before Facebook introduced the phrase. The company began to sell shares before lining up a single customer.
- [By Jonathan Yates]
Based in Minnesota, C.H. Robinson Worldwide offers global transportation services. It�is one of the largest holdings of Mairs & Power Growth, an excellent mutual fund that has a fondness for companies in Minnesota. Others include Hormel (NYSE: HRL) and 3M (NYSE: MMM). That is fine company for a medium cap like C.H. Robinson Worldwide to be associated with.
- [By Laura Brodbeck]
Thursday
Earnings Expected From: Caterpillar, Inc. (NYSE: CAT), Celgene Corporation (NASDAQ: CELG), Comcast Corporation (NASDAQ: CMCSA), Credit Suisse Group (NYSE: CS), Dunkin’ Brands Group, Inc. (NASDAQ: DNKN), Dow Chemical Company (NYSE: DOW), Eli Lilly Company (NYSE: LLY), Southwest Airlines Company (NYSE: LUV), 3M Company (NYSE: MMM), Microsoft Corporation (NASDAQ: MSFT), Unilever NV (NYSE: UN), Xerox Corporation (NYSE: XRX) Economic Releases Expected: French manufacturing PMI, French services PMI, German manufacturing PMI, German services PMI, Spanish unemployment rate, eurozone services PMI, eurozone manufacturing PMI, British retail sales, U.S. manufacturing PMI, eurozone consumer confidenceFriday